Published in Blood Weekly, October 30th, 2003
TTP "is an uncommon hematologic thrombotic disorder characterized by fever, hemorrhagic and neurologic signs," scientists in Italy explained. "The advent of plasma exchange has dramatically improved the prognosis of this disease, which was once inevitably fatal. However, mortality rates remain significant."
"Antiplatelet drugs have been widely used in combination with plasma exchange," noted G. Quintini and colleagues at the University of Palermo, who "investigated the effects of an adjunctive therapy consisting of the continuous, intravenous...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.